IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示,截至3月底,有9.414亿美元的现金、现金等价物和有价证券,预计将为2028年的运营提供资金
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示,截至3月底,有9.414亿美元的现金、现金等价物和有价证券,预计将为2028年的运营提供资金
使用浏览器的分享功能,分享给你的好友吧